Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Andreas Forsland, the founder and CEO of Cognixion, at his company’s Santa Barbara headquarters. The company recently closed a $12 million funding round. (Eric Isaacs photo) Santa Barbara-based Cognixion has received a Breakthrough Device designation from the U.S. Food and Drug Administration, the company announced on May 4, paving the way to get its artificial
U.S. FDA Breakthrough Device designations are granted to expedite the review of technologies with the potential to greatly impact those suffering from life...
Except for statements of historical fact, certain information described in this Form 10-Q report contains forward-looking statements that involve substantial risks and uncertainties. You can identify... | May 4, 2023
The Centers for Medicare & Medicaid Services (CMS or Agency) on April 10, 2023, published its annual proposed rule for the federal fiscal year (FY) 2024...
Blood-based measurement of neurofilament light chain provides compelling evidence to support an accelerated drug approval by the FDA. The decision has positive implications for NfL blood testing as... | June 18, 2023